Literature DB >> 24376327

Primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple local relapses: case presentation and brief review of literature.

A Patsatsi1, A Kyriakou1, V Karavasilis2, K Panteliadou1, D Sotiriadis1.   

Abstract

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBL-LT) is a primary cutaneous B-cell lymphoma of intermediate behavior. The disease predominantly affects elderly patients. A 76-year old man presented with red to violaceous nodules in the anterior aspect of both tibias. Histology confirmed the diagnosis of PCDLBL-LT. A thorough clinical and laboratory investigation was negative for any systemic involvement. However, computed tomography of the thorax showed mediastinal lymphadenopathy. Both bone marrow aspiration and trephine did not show any evidence of bone marrow infiltration. Initially R-CHOP regimen (rituximab-cyclophosphamide, doxorubicin, vincristine, prednisone) achieved a total clearance of the lesions. Nevertheless, five months later patient presented with a relapse and was managed with palliative radiotherapy. The same treatment modality was applied for the second recurrence, as well. PCDLBL-LT affects mostly elderly patients. The consequent age related comorbidities and the frequent relapses require a strict follow up of the patients.

Entities:  

Keywords:  B-cell cutaneous lymphoma; R-CHOP regimen; leg type (PCDLBL-LT); primary cutaneous diffuse large B-cell lymphoma

Year:  2013        PMID: 24376327      PMCID: PMC3743626     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  10 in total

1.  Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.

Authors:  Alexis Guyot; Nicolas Ortonne; Laurence Valeyrie-Allanore; Martine Bagot
Journal:  Arch Dermatol       Date:  2010-01

2.  Co-infection of human herpesvirus-6 and human herpesvirus-8 in primary cutaneous diffuse large B-cell lymphoma, leg type.

Authors:  Shoko Nakayama-Ichiyama; Taiji Yokote; Kazuki Iwaki; Takuji Miyoshi; Takayuki Takubo; Motomu Tsuji; Toshiaki Hanafusa
Journal:  Br J Haematol       Date:  2011-04-26       Impact factor: 6.998

3.  Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features.

Authors:  Cristina Muniesa; Ramon M Pujol; M Teresa Estrach; Fernando Gallardo; M Pilar García-Muret; Josefina Climent; Antonio Salar; Octavio Servitje
Journal:  J Am Acad Dermatol       Date:  2011-08-03       Impact factor: 11.527

4.  Primary cutaneous B-cell lymphomas.

Authors:  Werner Kempf; Natalja Denisjuk; Katrin Kerl; Antonio Cozzio; Christian Sander
Journal:  J Dtsch Dermatol Ges       Date:  2012-01       Impact factor: 5.584

5.  Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challenges.

Authors:  Marion Wobser; Hermann Kneitz; Eva-Bettina Bröcker; Jürgen Christian Becker
Journal:  J Dtsch Dermatol Ges       Date:  2010-12-02       Impact factor: 5.584

6.  Primary cutaneous large B-cell lymphoma, leg type.

Authors:  Vibha Thomas; Robin Dobson; Robert Mennel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-10

Review 7.  Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.

Authors:  Lubomir Sokol; Mojdeh Naghashpour; L Frank Glass
Journal:  Cancer Control       Date:  2012-07       Impact factor: 3.302

8.  Rituximab for primary cutaneous diffuse large B-cell lymphoma-leg type.

Authors:  Marion Fenot; Gaelle Quereux; Anabelle Brocard; Jean-Jacques Renaut; Brigitte Dreno
Journal:  Eur J Dermatol       Date:  2010-10-18       Impact factor: 3.328

9.  Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification.

Authors:  E M Bessell; C E Humber; S O'Connor; J S E English; W Perkins; P D Dickinson; A N Patel
Journal:  Br J Dermatol       Date:  2012-09-05       Impact factor: 9.302

Review 10.  Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations.

Authors:  Alexandra C Hristov
Journal:  Arch Pathol Lab Med       Date:  2012-08       Impact factor: 5.534

  10 in total
  5 in total

1.  Cutaneous lymphoma misdiagnosed as chronic lymphadenitis.

Authors:  Mircea Munteanu; Georgiana S Mohor; Flavia Baderca; Caius Solovan
Journal:  Int Wound J       Date:  2015-04-22       Impact factor: 3.315

2.  Widespread primary cutaneous diffuse large B-cell lymphoma, leg type, with nasal involvement.

Authors:  Ecem Bostan; Neslihan Akdogan; Arzu Saglam Ayhan; Sibel Ersoy Evans
Journal:  Int Wound J       Date:  2019-05-17       Impact factor: 3.315

3.  Relapsed Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.

Authors:  Shaohua Wu; Wei Gui; Liping Su; Yanfeng Xi
Journal:  Indian J Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.494

4.  Primary cutaneous diffuse large B-cell lymphoma after total knee arthroplasty: a case study and a systematic review of its cutaneous manifestations and treatment options.

Authors:  Changjun Chen; Meng Si; Xianlei Gao; Wenhan Wang; Songgang Wang; Xin Pan
Journal:  Postepy Dermatol Alergol       Date:  2021-08-16       Impact factor: 1.664

Review 5.  Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of R-CHOP chemotherapy and surgery: A case report and review of literature.

Authors:  Jinjing Jia; Wensheng Li; Yan Zheng
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.